Flu Season Alert: December 21 H3N2 Concerns Impact Biotech Stocks

The H3N2 influenza strain has emerged as a significant concern during the flu season 2025. As alerts heighten, both the public health sector and biotech companies are on high alert. Investors in Canada are keenly observing developments as the healthcare industry navigates potential impacts on biotech stocks. This situation presents both challenges and opportunities within the market, as firms race to adapt.